The World Congress on Interventional Therapies for Type 2 Diabetes was conceived by Prof Francesco Rubino as an international multi-disciplinary forum to discuss available evidence on the use and study of bariatric/metabolic surger, device-based interventions and other novel therapeutics for the treatment of type 2 diabetes. The congress serves to craft an agenda of research priorities and health policy initiatives.
The first edition of the world congress was held in New York City in September 2008 and was attended by delegates from over 65 countries. Three other editions were held in New York in 2011, London 2015 and again in New York in 2019.
The World Congress boasts a stellar Faculty of clinicians and scientists, including Nobel laureates and it is widely considered as the most prestigious multidisciplinary gathering entirely dedicated to the field of metabolic and diabetes surgery.
The congress includes workshops, symposia and plenary sessions with state-of-the art review lectures and panel discussions by world leading authorities in the field of diabetes, surgery, cardiology, internal medicine, nutrition, basic science and public health.
Interactive panel discussions are the signature feature of this congress, and are set up as a sort of talk-show, where Faculty members provide a critical appraisal of evidence and a discussion of its practical implications with attendees. The outcome of these discussions is used to craft an agenda of research priorities and health policy initiatives.
